Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1993-06-17
1994-07-12
Dees, Jose G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514533, 514538, 514562, 560 10, 560 13, 562429, 562430, A61K 3124, A61K 31195, C07C31712, C07C31714
Patent
active
053289323
ABSTRACT:
The present invention provides new thrombin inhibiting bisamidines derivatives, their pharmaceutically acceptable salts and hydrates, methods for their preparation, pharmaceutical composition, a process for their preparation, and use of the compounds in treatment of thrombosis, ischemia and stroke.
REFERENCES:
patent: 4041156 (1977-08-01), Okamoto et al.
patent: 4374248 (1983-02-01), Crenshaw et al.
patent: 4440933 (1984-04-01), Montzka
patent: 4537896 (1985-08-01), Cleason et al.
Balasubramanian Neelakantan
Han William Teh-Wei
Almaula Prabodh I.
Bristol--Myers Squibb Company
Clarke Vera C.
Dees Jos,e G.
LandOfFree
Bisamidine derivatives as thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bisamidine derivatives as thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bisamidine derivatives as thrombin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-396811